The SIRIC label

The French National Institute of Cancer has introduced a competitive site endorsement policy. This policy aims to provide new operational conditions for translational research in oncology that will optimize and accelerate the production of new knowledge and promote its dissemination and application in the treatment of cancers.

As such, the creation of integrated cancer research sites (SIRICs) should lead to significant changes in the conduction of multidisciplinary and integrated research

Source : French National Cancer Institute

SIRICs' mission

Elaborate and conduct a certain number of integrated research programs. The ultimate objective is to reduce the incidence of cancer and its mortality and to improve patient care.
Establish the necessary infrastructure and resources to conduct research responding to the criteria of excellence, innovation, integration, multidisciplinarity and transfer to the clinic
Ensure the application and dissemination of results and acquired knowledge

SIRIC funding

The French national cancer institute (INCa), the French health ministry (DGOS) and the French National Institute of Health and Medical Research (Inserm) on behalf of French National Alliance for Life Sciences and Health (Aviesan).